We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
You're enjoying temporary access to this content

Welcome to PracticeUpdate! We hope you are enjoying temporary access to this content. Please register today for a free account and gain full access to all of our expert-selected content.

Already Have An Account? Log in Now

Published in Dermatology

Journal Scan / Research · January 10, 2021

Association of Histologic Regression With a Favorable Outcome in Patients With Primary Cutaneous Melanoma

JAMA Dermatology




This abstract is available on the publisher's site.

Access this abstract now  

Additional Info

Disclosure statements are available on the authors' profiles:

JAMA Dermatology
Association of Histologic Regression With a Favorable Outcome in Patients With Stage 1 and Stage 2 Cutaneous Melanoma
JAMA Dermatol 2020 Dec 23;[EPub Ahead of Print], MA El Sharouni, K Aivazian, AJ Witkamp, V Sigurdsson, CH van Gils, RA Scolyer, JF Thompson, PJ van Diest, SN Lo

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading